On April 23, 2026, the US Department of Justice released an update to the scheduling of FDA-approved marijuana products and products containing marijuana to Schedule III with federal controls.

July 11, 2026

This link includes the formal press release – Office of Public Affairs | Justice Department Places FDA-Approved Marijuana Products and Products Containing Marijuana Subject to a Qualifying State-issued License in Schedule III, Strengthening Medical Research While Maintaining Strict Federal Controls | United States Department of Justice [justice.gov]